Skip to main content
SpringerLink
Log in

Special Issues in Older Women with Breast Cancer

  • Chapter
Improving Outcomes for Breast Cancer Survivors

Part of the book series: Advances in Experimental Medicine and Biology ((BCRF,volume 862))

Abstract

The true face of breast cancer is more commonly that of an older woman. The rapid aging of the US population is contributing to an increasing number of breast cancer cases in older adults today, as well as an increase in the number of breast cancer survivors who carry the long-term side effects of breast cancer treatment. The number one problem facing older women with breast cancer today is that they are not receiving the same benefits from treatment advances as younger women. This disparity in outcomes highlights the great need for studies that specially include older women with breast cancer in order to guide informed decisions regarding the most efficacious treatment options. Novel study designs are needed to fill these gaps in knowledge which include metrics that provide a detailed understanding of the individual beyond chronologic age, and which identify areas of vulnerability for which targeted interventions can be employed. In studying cancer therapeutics in older adults, metrics of success, beyond disease-free and overall survival should be included, such as the feasibility of delivering the therapy, as well as the impact of treatment on functional independence and cognition. Ultimately, this framework will lead to evidence-based “personalized” medicine for the older adult.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahles TA, Saykin AJ et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434–4440

    Article  PubMed Central  PubMed  Google Scholar 

  • Amir E, Seruga B et al (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103(17):1299–1309

    Article  CAS  PubMed  Google Scholar 

  • Aparicio T, Jouve JL et al (2013) Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. J Clin Oncol 31(11):1464–1470

    Article  CAS  PubMed  Google Scholar 

  • Braithwaite D, Satariano WA et al (2010) Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 102(19):1468–1477

    Article  PubMed Central  PubMed  Google Scholar 

  • NCI (National Cancer Institute) (2010) SEER cancer statistics factsheet: breast cancer. http://seer.cancer.gov/statfacts/html/breast.html. Retrieved 12 Mar 2014

  • Clough-Gorr KM, Ganz PA et al (2007) Older breast cancer survivors: factors associated with change in emotional well-being. J Clin Oncol 25(11):1334–1340

    Article  PubMed  Google Scholar 

  • Crivellari D, Bonetti M et al (2000) Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the international breast cancer study group trial VII. J Clin Oncol 18(7):1412–1422

    CAS  PubMed  Google Scholar 

  • Cuppone F, Bria E et al (2008) Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials. Cancer 112(2):260–267

    Article  CAS  PubMed  Google Scholar 

  • Dale W (2009) “Staging the aging” when considering androgen deprivation therapy for older men with prostate cancer. J Clin Oncol 27(21):3420–3422

    Article  PubMed  Google Scholar 

  • Dale W, Mohile SG et al (2012) Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst 104(8):581–589

    Article  PubMed Central  PubMed  Google Scholar 

  • Demark-Wahnefried W, Clipp EC et al (2006) Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from project LEAD. J Clin Oncol 24(21):3465–3473

    Article  PubMed Central  PubMed  Google Scholar 

  • DeSantis C, Ma J et al (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52–62

    Article  PubMed  Google Scholar 

  • Diab SG, Elledge RM et al (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92(7):550–556

    Article  CAS  PubMed  Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717

    Article  Google Scholar 

  • Eastell R, Adams JE et al (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 26(7):1051–1057

    Article  CAS  PubMed  Google Scholar 

  • Eblan MJ, Vanderwalde NA et al (2014) Hypofractionation for breast cancer: lessons learned from our neighbors to the north and across the pond. Oncology 28(6):536

    PubMed  Google Scholar 

  • Elkin EB, Hurria A et al (2006) Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol 24(18):2757–2764

    Article  PubMed  Google Scholar 

  • Extermann M, Boler I et al (2012) Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score. Cancer 118(13):3377–3386

    Article  PubMed  Google Scholar 

  • Freedman RA, Pitcher B et al (2013) Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on cancer and leukemia group B 49907. Breast Cancer Res Treat 139(2):607–616

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Freyer G, Geay JF et al (2005) Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 16(11):1795–1800

    Article  CAS  PubMed  Google Scholar 

  • Ganz PA, Guadagnoli E et al (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033

    Article  PubMed  Google Scholar 

  • Ganz PA, Hussey MA et al (2008) Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest oncology group protocol s8897. J Clin Oncol 26(8):1223–1230

    Article  CAS  PubMed  Google Scholar 

  • Goss PE, Ingle JN et al (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97(17):1262–1271

    Article  CAS  PubMed  Google Scholar 

  • Haviland JS, Owen JR et al (2013) The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14(11):1086–1094

    Article  PubMed  Google Scholar 

  • Hortobagyi GN (2007) A shortage of oncologists? The American society of clinical oncology workforce study. J Clin Oncol 25(12):1468–1469

    Article  PubMed  Google Scholar 

  • Hughes K, Schnaper L et al (2010) Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer [abstract]. J Clin Oncol 28(Suppl 15)

    Google Scholar 

  • Hurria A, Rosen C et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54(6):925–931

    Article  PubMed  Google Scholar 

  • Hurria A, Togawa K et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29(25):3457–3465

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Institute of Medicine (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. The National Academies Press, Washington, DC

    Google Scholar 

  • IOM (2008) Retooling for an aging America: building the healthcare workforce. The National Academies Press, Washington, DC

    Google Scholar 

  • Jones LW, Courneya KS et al (2012) Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 30(20):2530–2537

    Google Scholar 

  • Kemeny MM, Peterson BL et al (2003) Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21(12):2268–2275

    Article  PubMed  Google Scholar 

  • Kimmick GG, Peterson BL et al (2005) Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol 23(10):2201–2207

    Article  PubMed  Google Scholar 

  • Kimmick G, Fleming ST et al (2014) Comorbidity burden and guideline-concordant care for breast cancer. J Am Geriatr Soc 62(3):482–488

    Article  PubMed  Google Scholar 

  • Koppelmans V, Breteler MM et al (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30(10):1080–1086

    Article  PubMed  Google Scholar 

  • Kornblith AB, Kemeny M et al (2002) Survey of oncologists’ perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95(5):989–996

    Article  PubMed  Google Scholar 

  • Kornblith AB, Lan L et al (2011) Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol 29(8):1022–1028

    Article  PubMed Central  PubMed  Google Scholar 

  • Lakoski SG, Barlow CE et al (2013) The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res Treat. 138(3): 909–916

    Google Scholar 

  • Lewis JH, Kilgore ML et al (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21(7):1383–1389

    Article  PubMed  Google Scholar 

  • Mandelblatt JS, Sheppard VB et al (2010) Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol 28(19):3146–3153

    Article  PubMed Central  PubMed  Google Scholar 

  • Mandelblatt JS, Faul LA et al (2012) Patient and physician decision styles and breast cancer chemotherapy use in older women: cancer and leukemia group B protocol 369901. J Clin Oncol 30(21):2609–2614

    Article  PubMed Central  PubMed  Google Scholar 

  • Mandelblatt JS, Hurria A et al (2013) Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol 40(6):709–725

    Article  PubMed  Google Scholar 

  • Mieog JS, Morden JP et al (2012) Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the intergroup exemestane study. Lancet Oncol 13(4):420–432

    Article  PubMed  Google Scholar 

  • Murthy VH, Krumholz HM et al (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726

    Article  CAS  PubMed  Google Scholar 

  • Muss HB, Woolf S et al (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293(9):1073–1081

    Article  CAS  PubMed  Google Scholar 

  • Muss HB, Berry DA et al (2007) Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the cancer and leukemia group B experience. J Clin Oncol 25(24):3699–3704

    Article  CAS  PubMed  Google Scholar 

  • Muss HB, Berry DA et al (2009) Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 360(20):2055–2065

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Paik S, Shak S et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817–2826

    Article  CAS  PubMed  Google Scholar 

  • Pallis AG, Hatse S et al (2014) Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging? J Geriatr Oncol 5(2):204–218

    Article  PubMed  Google Scholar 

  • Parry C, Kent EE et al (2011) Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 20(10):1996–2005

    Article  PubMed Central  PubMed  Google Scholar 

  • Partridge AH, Archer L et al (2010) Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 28(14):2418–2422

    Article  PubMed Central  PubMed  Google Scholar 

  • Patnaik JL, Byers T et al (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111

    Article  PubMed Central  PubMed  Google Scholar 

  • Perez EA, Josse RG et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24(22):3629–3635

    Article  CAS  PubMed  Google Scholar 

  • Perez EA, Suman VJ et al (2008) Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group N9831 adjuvant breast cancer trial. J Clin Oncol 26(8):1231–1238

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Piccart-Gebhart MJ, Procter M et al (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353(16):1659–1672

    Article  CAS  PubMed  Google Scholar 

  • Romond EH, Perez EA et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353(16):1673–1684

    Article  CAS  PubMed  Google Scholar 

  • Sanoff HK, Deal AM et al (2014) Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst 106(4):dju057

    Article  PubMed Central  PubMed  Google Scholar 

  • Schairer C, Mink PJ et al (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96(17):1311–1321

    Article  PubMed  Google Scholar 

  • Scher KS, Hurria A (2012) Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol 30(17):2036–2038

    Article  PubMed  Google Scholar 

  • Sehl M, Lu X et al (2013) Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women. J Cancer Surviv 7(1):20–31

    Article  PubMed Central  PubMed  Google Scholar 

  • Siegel R, DeSantis C et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241

    Article  PubMed  Google Scholar 

  • Siegel R, Ma J et al (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

    Article  PubMed  Google Scholar 

  • Slamon D, Eiermann W et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273–1283

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Smith BD, Smith GL et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765

    Article  PubMed  Google Scholar 

  • Smith BD, Jiang J et al (2011) Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol 29(35):4647–4653

    Article  PubMed  Google Scholar 

  • Soulos PR, Yu JB et al (2012) Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol 30(14):1601–1607

    Article  PubMed Central  PubMed  Google Scholar 

  • Suter TM, Procter M et al (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25(25):3859–3865

    Article  CAS  PubMed  Google Scholar 

  • Talarico L, Chen G et al (2004) Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US food and drug administration. J Clin Oncol 22(22):4626–4631

    Article  PubMed  Google Scholar 

  • Tan-Chiu E, Yothers G et al (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23(31):7811–7819

    Article  CAS  PubMed  Google Scholar 

  • Unger JM, Coltman CA Jr et al (2006) Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 24(1):141–144

    Article  PubMed  Google Scholar 

  • Yamada TH, Denburg NL et al (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22(1):48–54

    Article  PubMed Central  PubMed  Google Scholar 

  • Yourman LC, Lee SJ et al (2012) Prognostic indices for older adults: a systematic review. JAMA 307(2):182–192

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. City of Hope, 1500 E Duarte Road, Duarte, CA, 91010, USA

    Arti Hurria M.D.

  2. University of North Carolina, Chapel Hill, NC, USA

    Hy Muss M.D.

Authors
  1. Arti Hurria M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hy Muss M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arti Hurria M.D. .

Editor information

Editors and Affiliations

  1. Distinguished Professor of Health Policy & Management and Medicine, Director, Cancer Prevention & Control Research, UCLA Fielding School of Public Health, David Geffen School of Medicine at UCLA, Jonsson Comprehensive Cancer Center, Los Angeles, California, USA

    Patricia A. Ganz

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Breast Cancer Research Foundation

About this chapter

Cite this chapter

Hurria, A., Muss, H. (2015). Special Issues in Older Women with Breast Cancer. In: Ganz, P. (eds) Improving Outcomes for Breast Cancer Survivors. Advances in Experimental Medicine and Biology(), vol 862. Springer, Cham. https://doi.org/10.1007/978-3-319-16366-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation